REQUEST A DEMO
Total
USD $0.00
Search more companies

Vefa Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Vefa Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: March 05, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vefa Ilac A.S. is an enterprise in Turkiye, with the main office in Istanbul. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on February 24, 2011. There are currently 390 (2026) people employed by Vefa Ilac A.S.. In its most recent financial highlights, the company reported a net sales revenue increase of 76.93% in 2023. Its’ total assets recorded a growth of 100.79%. The enterprise’s net profit margin decreased by 3.31% in 2023.

Headquarters
No:3-2 Beylikduzuosb Mahallesi 2 Caddesi Beylikduzu
Istanbul; Marmara; Postal Code: 34524

Contact Details: Purchase the Vefa Ilac A.S. report to view the information.

Website: http://www.vefailac.com.tr

Basic Information
Total Employees:
Purchase the Vefa Ilac A.S. report to view the information.
Financial Auditors:
Purchase the Vefa Ilac A.S. report to view the information.
Incorporation Date:
February 24, 2011
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Vefa Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
76.93%
Total Operating Revenue
76.93%
Operating Profit
105.42%
Net Profit/Loss for the Period
59.05%
Total Assets
100.79%
Total Equity
120.62%
Operating Profit Margin
5.28%
Net Profit Margin
-3.31%
Return on Equity (ROE)
-12.65%
Debt / Equity
-1.99%
Quick Ratio
-0.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?